aTyr Pharma (LIFE) Tops Q3 EPS by 18c

aTyr Pharma (NASDAQ: LIFE) reported Q3 EPS of ($0.42), $0.18 better than the analyst estimate of ($0.60).

Cash, cash equivalents and investments as of September 30, 2021 were $116.4 million.

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• ABM Industries (ABM) Reports In-Line Q3 EPS; raises guidance
• Mission Produce (AVO) Misses Q3 EPS by 2c; offers outlook